Literature DB >> 10598937

Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation.

Y H Chiang1, S Z Lin, C V Borlongan, B J Hoffer, M Morales, Y Wang.   

Abstract

The authors, and others, have recently reported that intracerebral administration of glial cell line-derived neurotrophic factor (GDNF) or osteogenic protein-1 protects against ischemia-induced injury in the cerebral cortex of adult rats. Because these trophic factors are highly expressed in the fetal, but not adult, kidney cortex, the possibility that transplantation of fetal kidney tissue could serve as a cellular reservoir for such molecules and protect against ischemic injury in cerebral cortex was examined. Fetal kidneys obtained from rat embryos at gestational day 16, and adult kidney cortex, were dissected and cut into small pieces. Adult male Sprague-Dawley rats were anesthetized with chloral hydrate and placed in a stereotactic apparatus. Kidney tissues were transplanted into three cortical areas adjacent to the right middle cerebral artery (MCA). Thirty minutes after grafting, the right MCA was transiently ligated for 90 minutes. Twenty-four hours after the onset of reperfusion, animals were evaluated behaviorally. It was found that the stroke animals that received adult kidney transplantation developed motor imbalance. However, animals that received fetal kidney grafts showed significant behavioral improvement. Animals were later sacrificed and brains were removed for triphenyltetrazolium chloride staining, Pax-2 immunostaining, and GDNF mRNA expression. It was noted that transplantation of fetal kidney but not adult kidney tissue greatly reduced the volume of infarction in the cerebral cortex. Fetal kidney grafts showed Pax-2 immunoreactivity and GDNF mRNA in the host cerebral cortex. In contrast, GDNF mRNA expression was not found in the adult kidney grafts. Taken together, our data indicate that fetal kidney transplantation reduces ischemia/reperfusion-induced cortical infarction and behavioral deficits in adult rats, and that such tissue grafts could serve as an unique cellular reservoir for trophic factor application to the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598937     DOI: 10.1097/00004647-199912000-00006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  11 in total

Review 1.  Stem cell therapy for neurological disorders: A focus on aging.

Authors:  Hung Nguyen; Sydney Zarriello; Alexandreya Coats; Cannon Nelson; Chase Kingsbury; Anna Gorsky; Mira Rajani; Elliot G Neal; Cesar V Borlongan
Journal:  Neurobiol Dis       Date:  2018-09-13       Impact factor: 5.996

Review 2.  Developments in intracerebral stem cell grafts.

Authors:  Stephanny Reyes; Naoki Tajiri; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-03-05       Impact factor: 4.618

3.  Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats.

Authors:  Mikko Airavaara; Hui Shen; Chi-Chung Kuo; Johan Peränen; Mart Saarma; Barry Hoffer; Yun Wang
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

4.  An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of stroke.

Authors:  B K Harvey; G J Chen; C J Schoen; C T Lee; D B Howard; O Dillon-Carter; M Coggiano; W J Freed; Y Wang; B J Hoffer; J F Sanchez
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

5.  Effect of intranigral injection of GDNF and EGF on the survival and possible differentiation fate of progenitors and immature neurons in 6-OHDA-lesioned rats.

Authors:  Zheng-Quan Yu; Ji-Hui Zha; Hong-Mei Liu; Yan-Xia Ding; Yan-Qian Wang; Hong-Jun Wang; Dian-Shuai Gao
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 6.  Elevated body swing test after focal cerebral ischemia in rodents: methodological considerations.

Authors:  Edvin Ingberg; Johanna Gudjonsdottir; Elvar Theodorsson; Annette Theodorsson; Jakob O Ström
Journal:  BMC Neurosci       Date:  2015-08-05       Impact factor: 3.288

7.  Role of two sequence motifs of mesencephalic astrocyte-derived neurotrophic factor in its survival-promoting activity.

Authors:  K Mätlik; Li-ying Yu; A Eesmaa; M Hellman; P Lindholm; J Peränen; E Galli; J Anttila; M Saarma; P Permi; M Airavaara; U Arumäe
Journal:  Cell Death Dis       Date:  2015-12-31       Impact factor: 8.469

Review 8.  Melatonin-based therapeutics for neuroprotection in stroke.

Authors:  Kazutaka Shinozuka; Meaghan Staples; Cesar V Borlongan
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

9.  Neuroprotective Action of Human Wharton's Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Pei-Chi Tseng; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Cell Transplant       Date:  2018-10-04       Impact factor: 4.064

Review 10.  Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Brain Circ       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.